Stock Earnings

Question 1

What are Infant Bacterial Therapeutics AB's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Infant Bacterial Therapeutics AB has a total asset of $239, Net loss of $-136

Question 2

What are the key financial ratios for IFTBF?

Accepted Answer

Infant Bacterial Therapeutics AB's Current ratio is 3.46, has a Net margin is 0, sales per share of $0.

Question 3

How is Infant Bacterial Therapeutics AB's revenue broken down by segment or geography?

Accepted Answer

Currently Infant Bacterial Therapeutics AB data is not available.

Question 4

Is Infant Bacterial Therapeutics AB profitable?

Accepted Answer

no, according to the latest financial statements, Infant Bacterial Therapeutics AB has a net loss of $-136

Question 5

Does Infant Bacterial Therapeutics AB have any liabilities?

Accepted Answer

yes, Infant Bacterial Therapeutics AB has liability of 69

Question 6

How many outstanding shares for Infant Bacterial Therapeutics AB?

Accepted Answer

Infant Bacterial Therapeutics AB has a total outstanding shares of 13.47

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	20	19	13	--	--	--
Research & Development	88	126	121	65	44	72
Operating Expenses	108	145	134	65	44	71
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-102	-136	-123	-65	-44	-72
Income Tax Expense	--	--	--	--	--	--
Net Income	-102	-136	-123	-65	-44	-72
Net Income Growth	-28%	11%	89%	48%	-39%	56.99%
Shares Outstanding (Diluted)	13.47	13.47	12.36	11.22	11.22	11.22
Shares Change (YoY)	0%	9%	10%	0%	0%	0%
EPS (Diluted)	-7.59	-10.16	-9.95	-5.83	-4	-6.41
EPS Growth	-28%	2%	71%	45%	-38%	55%
Free Cash Flow	-94	-113	-101	-85	-55	-58
Free Cash Flow Per Share	-6.97	-8.38	-8.16	-7.57	-4.89	-5.16
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-108	-145	-134	-65	-44	-71
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-108	-145	-134	-65	-44	-71
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Infant Bacterial Therapeutics AB (IFTBF) Price